Clinical Trials Browser

Pancreatic Adenocarcinoma × durvalumab × 1 year × Clear all

NCT03245541 2025-10-07

Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer

Phase 1/2 Active not recruiting

Gastrointestinal

Pancreatic Adenocarcinoma